Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dynaco (Nanjing) Biotechnology is a high-tech enterprise specializing in the research, development, and manufacturing of in vitro diagnostic (IVD) reagents and instruments. The company focuses on providing comprehensive solutions for molecular diagnostics, particularly in the areas of infectious disease screening and genetic testing. Its core product portfolio includes automated nucleic acid extraction systems, PCR detection kits, and chemiluminescence reagents. Dynaco serves clinical laboratories, hospitals, and research institutions by offering high-sensitivity diagnostic tools for pathogens such as HBV, HCV, and HIV. The company is headquartered in Nanjing, China, and maintains a strong focus on the domestic IVD market while expanding its technological capabilities in automated laboratory systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dynaco.